EdgarLookup

Novartis Institutes for BioMedical Research, Inc.

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Novartis Institutes for BioMedical Research, Inc.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

NTLA
Company Title Type Shares Price Value Date
NTLA Other 25,074 Jul 16, 2018
0001718108 C 909,090 Apr 23, 2018
NTLA Sale 1,523,000 $18.30 $27,870,900 Dec 12, 2017
NTLA Other 79,245 Mar 3, 2017
NTLA C 1,724,240 May 11, 2016